Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 09, 2015 8:52 PM ET


Company Overview of Verdezyne, Inc.

Company Overview

Verdezyne, Inc. operates as an industrial biotechnology company. It creates bio-based processes that offer clean and sustainable fuels and chemicals. The company designs and engineers enzymes, metabolic pathways, and microorganisms that produce target chemicals. Verdezyne, Inc. was formerly known as CODA Genomics, Inc. and changed its name to Verdezyne, Inc. in Novemeber 2008. Verdezyne, Inc. was founded in 2005 and is based in Carlsbad, California.

2715 Loker Avenue West

Carlsbad, CA 92010

United States

Founded in 2005





Key Executives for Verdezyne, Inc.

Chief Executive Officer and President
Chief Financial Officer
Senior Vice President of Intellectual Property and General Counsel
Vice President of Development
Principal Biologist
Compensation as of Fiscal Year 2015.

Verdezyne, Inc. Key Developments

Verdezyne, Inc. Reaches an Agreement with Will & Co

Verdezyne announced it has reached an agreement with Will & Co, a sales and marketing firm for raw materials, semifinished products, additives, and pigments, for distributing Verdezyne's first commercial product. The exclusive agreement is for the sales and distribution of biobased dodecanedioic acid (DDDA) in Europe. The DDDA will be produced at Verdezyne's commercial-scale plant in Malaysia. The 10,000-m.t./year diacids plant is expected to open in 2017. The agreement secures offtake for over 25% of the expected plant capacity.

Verdezyne, Inc. Signs Agreement with Will & Co

Verdezyne, Inc. has reached an agreement with Will & Co. The exclusive agreement is for sales and distribution of BIOLON DDDA (biobased dodecanedioic acid or 'DC12') in Europe. BIOLON DDDA will be produced at Verdezyne’s commercial-scale plant in Malaysia. The agreement secures off-take for over 25% of the expected plant capacity. Verdezyne’s BIOLON DDDA is produced more sustainably than traditional petroleum-derived intermediate chemicals and will be used to make engineering polymer resins, automotive parts, toothbrush bristles, cosmetics, fragrances, and more.

Verdezyne, Inc. Presents at World Congress on Industrial Biotechnology, Jul-20-2015 10:30 AM

Verdezyne, Inc. Presents at World Congress on Industrial Biotechnology, Jul-20-2015 10:30 AM. Venue: Palais des congrès de Montréal, Montréal, Quebec, Canada. Speakers: Ray W. Miller, Chief Business Officer.

Similar Private Companies By Industry

Company Name Region
Heritage Inks International Corporation United States
Calumet Lubricants Co., Limited Partnership United States
Phoenix Chemical Co., Inc. United States
Bayer-Pursell, LLC United States
Axel Americas LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Verdezyne, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at